AcelRx Pharmaceuticals’ $32.5 Million Acquisition of Lowell Therapeutics

Sonia Carcano
Tagged:

Burns & Levinson LLP represented Lowell Therapeutics, Inc. in its sale to AcelRx Pharmaceuticals. AcelRx Pharmaceuticals (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here